Skip to content

Observation of Oliceridine Fumarate in Burn Patients

Observation of Oliceridine Fumarate in Burn Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126199
Enrollment
Unknown
Registered
2026-06-05
Start date
2026-06-06
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn

Interventions

Control group, experimental group:Anesthesia induction and postoperative analgesia using Sufentanil
Experimental group:Anesthesia induction and postoperative analgesia using oxaliplatin

Sponsors

Heze Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.ASAI and II grade patients, aged 18-75 years, 2. BMI 18-28 kg/m2, 3.with mild to moderate burns.

Exclusion criteria

Exclusion criteria: 1.History of cardiovascular and pulmonary dysfunction, with pulmonary function indicating moderate to severe pulmonary ventilation dysfunction; Patients with heart failure and circulatory failure, etc. For patients allergic to oxaliplatin and sufentanil; 2.Participated in other clinical trials within 4 weeks prior to the start of the study; Emergency patients who cannot undergo sufficient preoperative preparation; Patients with organic heart disease before surgery (such as sinus syndrome, atrioventricular block, etc.); 3.Patients with severe dehydration, electrolyte imbalance, and shock; Pregnant, planned pregnant, or lactating female patients; Patients with neurological or psychiatric disorders, severe alcohol abuse, and a history of long-term high-dose use of sedatives; 4.Patients with severe respiratory dysfunction before surgery; Acute or severe bronchial asthma in an unmonitored environment or without resuscitation equipment.

Design outcomes

Primary

MeasureTime frame
Numerical Simulation Score (NRS);

Secondary

MeasureTime frame
Wake-up time;

Countries

China

Contacts

Public ContactGuo jiyan

Heze Municipal Hospital

704256727@qq.com+86 183 5306 3176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026